戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 h permeability edema), and nitrite/ nitrate (nitric oxide production).
2  nitrite/nitrate concentrations (a marker of nitric oxide production).
3  receptors and increase cytosolic Ca(2+) and nitric oxide production.
4 by limiting LDL oxidation via stimulation of nitric oxide production.
5 ide, but rather to suppression of macrophage nitric oxide production.
6 e effector response by increasing macrophage nitric oxide production.
7 ial nitric oxide synthase protein levels and nitric oxide production.
8 ilization of dysfunctional EPCs with blocked nitric oxide production.
9 ascular endothelial growth factor-stimulated nitric oxide production.
10  the increases were blocked by inhibitors of nitric oxide production.
11 be involved in the regulation of endothelial nitric oxide production.
12 se regulator function and is associated with nitric oxide production.
13 icant negative correlation between TCF11 and nitric oxide production.
14 al cofactor for catecholamine, serotonin and nitric oxide production.
15 fects are prevented by restoring endothelial nitric oxide production.
16 s, in a dose-dependent manner, and triggered nitric oxide production.
17 nducing arginase I expression and inhibiting nitric oxide production.
18 igation by stimulating pulmonary endothelial nitric oxide production.
19 nvolved in acid resistance and inhibits host nitric oxide production.
20 tion of nuclear factor-kappaB activation and nitric oxide production.
21  COX-2 increases 4-HPR-induced apoptosis and nitric oxide production.
22 roxyphenyl)retinamide (4-HPR) by suppressing nitric oxide production.
23 -activated pathways, endotoxin tolerance, or nitric oxide production.
24 te interleukin-6 secretion but did not alter nitric oxide production.
25  nitric oxide synthase, leading to decreased nitric oxide production.
26 res, but to have no effect on LPS-stimulated nitric oxide production.
27 euronal nitric oxide synthase activation and nitric oxide production.
28 ects of LPS by inhibiting the stimulation of nitric oxide production.
29 h as proliferation, particle engulfment, and nitric oxide production.
30 sduction of ICSBP with IRF-1 clearly induces nitric oxide production.
31 ter Eph B4 stimulation, indicating increased nitric oxide production.
32 ed bone resorption in the presence of normal nitric oxide production.
33 ation, reduced HO-1 expression and increased nitric oxide production.
34 oxide synthase from caveolae, and preventing nitric oxide production.
35  cytokine-stimulated granuloma formation and nitric oxide production.
36 nd IFN-gamma resulted in iNOS expression and nitric oxide production.
37 mal coupling of extracellular stimulation to nitric oxide production.
38 l recovery, which manifest as an increase in nitric oxide production.
39 iotensin system and inhibition of intrarenal nitric oxide production.
40 y IC + IFN-gamma-induced iNOS expression and nitric oxide production.
41 e, despite displaying a marked deficiency in nitric oxide production.
42 pha-melanocyte-stimulating hormone decreased nitric oxide production.
43 ducible nitric-oxide synthase expression and nitric oxide production.
44 er trauma-hemorrhage via endothelial derived nitric oxide production.
45 l immunity, gamma interferon production, and nitric oxide production.
46 compromised in their ability to downregulate nitric oxide production.
47 ascular resistance and disturbed endothelial nitric oxide production.
48 re abolished by inhibition of either AMPK or nitric oxide production.
49 e from THP-1 cells as well as superoxide and nitric oxide production.
50 laxation of human and animal airways through nitric oxide production.
51  airway nerves as the source of TLR7-induced nitric oxide production.
52 on through nitric oxide synthase 2-dependent nitric oxide production.
53 re associated with HIF isoform regulation of nitric oxide production.
54  +/- 120.1 micromol/l, p = 0.003), decreased nitric oxide production (25.2 +/- 10.8 micromol/l to 22.
55 a stronger bactericidal activity with higher nitric oxide production, a more proinflammatory polarize
56 zed E(h) of Cys/CySS stimulated H2O2 but not nitric oxide production, activated nuclear factor-kappaB
57  play an essential role in the regulation of nitric oxide production after a septic challenge.
58  low-density lipoprotein reduces endothelial nitric oxide production (an important mediator of vasore
59         Previous studies documented impaired nitric oxide production and altered caveolin expression
60  TMEV infection through preemptive antiviral nitric oxide production and antiviral STAT1 activation.
61 rom the internal store in endothelial cells, nitric oxide production and artery relaxation.
62 hosphorylation of eNOS, whereas it decreased nitric oxide production and bioactivity.
63  effect of soy isoflavone supplementation on nitric oxide production and blood pressure in menopausal
64 drial Ang system is coupled to mitochondrial nitric oxide production and can modulate respiration.
65        Tumor necrosis factor-alpha increased nitric oxide production and caused similar increase in S
66  MDSCs with ibrutinib significantly impaired nitric oxide production and cell migration.
67                                          The nitric oxide production and cytokine secretion in rat pe
68 ion of renal kallikrein expression increased nitric oxide production and dampened renal superoxide pr
69                      Moreover, DATS restored nitric oxide production and decreased endothelial nitric
70  synthesis, restored cellular BH4 levels and nitric oxide production and decreased radiation-induced
71  activated the JAK/STAT1/IRF1 axis, inducing nitric oxide production and driving caspase-8/FADD-media
72      Finally, HHcy potentiated HG-suppressed nitric oxide production and eNOS activity in HAECs, whic
73 suring mechanosensing, which is essential to nitric oxide production and flow-induced vasodilation.
74 important role in the regulation of iNOS and nitric oxide production and hence could account for some
75 ortance of the simultaneous consideration of nitric oxide production and inactivation when investigat
76 ally ill patients with sepsis have increased nitric oxide production and increased bone resorption, w
77                        Milder suppression of nitric oxide production and inducible nitric oxide synth
78 ed in a significant decrease in MCAO-induced nitric oxide production and inducible nitric-oxide synth
79        Th1 cells, but not Th2 cells, induced nitric oxide production and inhibited intracellular para
80 nt macrophages, stimulating iNOS expression, nitric oxide production and interleukin-1 (IL-1) release
81             This cascade requires prostanoid/nitric oxide production and is independent of Wnt/LRP5.
82 ability to activate macrophages in vitro for nitric oxide production and killing of Leishmania major
83  soy isoflavone supplementation to stimulate nitric oxide production and lower blood pressure in meno
84 ormal vascular function via endothelial cell nitric oxide production and modulation of Ca(2+) handlin
85                                         Limb nitric oxide production and muscle phospho-endothelial n
86                                Inhibitors of nitric oxide production and of SNO blocked PAF-induced S
87  features of microglial activation including nitric oxide production and phagocytosis.
88 ssociated with increased iNOS expression and nitric oxide production and prevented by L-NIO, an enzym
89 ave found reductions of basal and stimulated nitric oxide production and responses to exogenous nitri
90          Insights into mechanisms regulating nitric oxide production and signaling and their integrat
91 response requires protein kinase A-dependent nitric oxide production and subsequent PAK2 phosphorylat
92 nostic tests, including measurement of nasal nitric oxide production and systematic analysis for muta
93 eprived motor neuron survival by suppressing nitric oxide production and the consequent peroxynitrite
94 ilar to estrogens, are believed to stimulate nitric oxide production and thus lower blood pressure.
95  nitric oxide synthase (iNOS) expression and nitric oxide production and to inhibit beta cell functio
96  antagonist, anakinra, efficiently decreased nitric oxide production and vascular proliferation and r
97 ly in neurons, is critical for CO(2)-induced nitric oxide production and vasodilation.
98 s hypertension and atherosclerosis, in which nitric oxide production and/or biological activity is im
99  Tyr-99 revealed that this nitration reduces nitric-oxide production and increases eNOS decoupling co
100 duced increase in urinary nitrates/nitrites (nitric oxide production) and 8-isoprostane (oxidative st
101  (CPSI, related to urea cycle and endogenous nitric oxide production) and complement factor H-related
102 ated protein product has defects in folding, nitric oxide production, and binding of cofactors.
103 nteractions in vivo by endothelial-dependent nitric oxide production, and by direct modulation of leu
104 , regulates permeability, leukocyte traffic, nitric oxide production, and coagulation, and harbors di
105 ibit increased gamma interferon (IFN-gamma), nitric oxide production, and delayed-type hypersensitivi
106 factor-kappaB (NF-kappaB) subunit p65, lower nitric oxide production, and diminished CHOP expression
107 resulted in impaired fungicidal ability, low nitric oxide production, and elevated synthesis of inter
108 etermining organism survival, superoxide and nitric oxide production, and expression of the cytokines
109 ndothelial nitric oxide synthase expression, nitric oxide production, and heme oxygenase-1 (HO-1) exp
110  nitric oxide synthase uncoupling, decreased nitric oxide production, and increased superoxide genera
111 essed by proliferation rate, apoptosis rate, nitric oxide production, and inflammatory markers TNF-al
112 II (inducible) nitric oxide synthase (iNOS), nitric oxide production, and inhibition of DNA synthesis
113 rditis virus (EMCV)-induced iNOS expression, nitric oxide production, and iPLA2 enzymatic activity in
114 's anti-Plasmodium defense as a substrate of nitric oxide production, and its availability therefore
115 ssel permeability, leukocyte/EC interaction, nitric oxide production, and mechanotransduction.
116 ltures, and gene expression, collagenase and nitric oxide production, and NF-kappaB activation were d
117 otein kinase C translocation and activation, nitric oxide production, and nitric oxide-activated poly
118     Total leukocyte counts, myeloperoxidase, nitric oxide production, and proteins were all significa
119 loperoxidase activity and total cell counts, nitric oxide production, and proteins.
120 otaxis, endothelial inflammation, oxidation, nitric oxide production, and thrombosis reveal other dim
121 that high doses of nonspecific inhibitors of nitric oxide production are contraindicated in septic sh
122 uced energy deficiency, and (ii) the role of nitric oxide production as a potential mechanism for ene
123 s, and considerable evidence points to local nitric oxide production as an important but complex regu
124 activate macrophage NF-kappa B signaling and nitric oxide production, as well as the MAP kinase p38,
125 ctivator of transcription (STAT) pathway and nitric oxide production, as well as the promotion of ade
126 cid citrulline, which may reflect changes in nitric oxide production, as well as various phospho- and
127 rn, Northern, and Western blot analysis, and nitric oxide production assays.
128 ile there can be detrimental consequences of nitric oxide production at pathological concentrations,
129 osure to high glucose, with the reduction in nitric oxide production being the most notable.
130 the TLR7 antagonist IRS661 and by inhibiting nitric oxide production but not by inhibiting prostaglan
131 ucible nitric oxide synthase, also increased nitric oxide production but this response was reduced by
132 ent of zinc deficiency-induced intracellular nitric oxide production but was attenuated by the additi
133 is dependent on NMDA receptor activation and nitric oxide production, but little else is known about
134 ing pathway is not involved in TNF-alpha and nitric oxide production, but, interestingly, negatively
135                                Inhibition of nitric oxide production by activated macrophages by usin
136 using the Limulus amebocyte lysate assay and nitric oxide production by alveolar macrophage.
137 sors have been used to measure extracellular nitric oxide production by BALB/c mouse macrophages.
138                                              Nitric oxide production by cells subjected to pulsatile
139                                              Nitric oxide production by cultured cells was measured e
140                                AM stimulates nitric oxide production by endothelial cells, whereas PA
141                                  Deficits in nitric oxide production by endothelial nitric oxide synt
142 te-macrophage colony-stimulating factor] and nitric oxide production by human and murine monocyte/mac
143 I-C) + IFN-gamma-induced iNOS expression and nitric oxide production by human islets are prevented by
144  Gram-negative bacteria induces cytokine and nitric oxide production by inflammatory cell types.
145  that lipopolysaccharide increases medullary nitric oxide production by iNOS induction, resulting in
146 in complement-mediated phagocytosis, inhibit nitric oxide production by macrophage-like cells, protec
147 IFN-gamma fails to induce iNOS expression or nitric oxide production by macrophages isolated from IRF
148 I isozymes, participate in the regulation of nitric oxide production by modulating the availability o
149 A + IFN-gamma-stimulated iNOS expression and nitric oxide production by mouse islets.
150 sRNA + IFN-gamma-induced iNOS expression and nitric oxide production by mouse peritoneal macrophages
151                                              Nitric oxide production by pex cells was dependent upon
152  nitric oxide synthase (iNOS) expression and nitric oxide production by rat, mouse, and human islets.
153                                NOS-dependent nitric oxide production by S. scabies was also reduced i
154 arinic and nicotinic receptor activation and nitric oxide production by using immunocytochemistry for
155                                              Nitric oxide production by various routes was sufficient
156              Estrogen receptor regulation of nitric oxide production by vascular endothelium may invo
157 ietary supplementation aimed to increase the nitric oxide production can also be beneficial.
158                         Thus, differences in nitric oxide production cannot account for the different
159  guanosine 3', 5'-monophosphate, an index of nitric oxide production, compared with WT mice.
160 Previous studies have suggested that loss of nitric oxide production contributes to these changes.
161 onstitutive iNOS expression and, implicitly, nitric oxide production, contributing to the poor surviv
162 trogen receptor (ER)-mediated stimulation of nitric oxide production, demonstrated by preinjecting th
163                                     Elevated nitric oxide production did not occur after FAK depletio
164                                Inhibition of nitric oxide production did not significantly affect the
165                                              Nitric oxide production doubles within 10 min exposure t
166  is important for developing ways to control nitric oxide production during angiogenesis and in many
167            NNFC caused a progressive drop in nitric oxide production during flow cessation followed b
168                           Blocking CX3CR1 or nitric oxide production during G-CSF treatment reduces e
169                 Phagocytic cell reduction in nitric oxide production during interactions with cryptoc
170 nal hyperemia by suppressing NMDAR-dependent nitric oxide production during neural activity.
171  chemokine expression, cell recruitment, and nitric oxide production during primary LVS infection and
172  factor alpha (TNF-alpha) mRNA and increased nitric oxide production during T. parva lethal infection
173 g either CD23 upregulation or CD23-dependent nitric oxide production eliminated the enhanced antifung
174  had no effect, and inhibition of endogenous nitric oxide production failed to increase TF expression
175 s fast responses and an initial overshoot of nitric oxide production for given doses of TNF and IFN-g
176  72 h was shown to dose-dependently increase nitric oxide production from 6-day-old retinal cultures.
177 , which were consistently unable to suppress nitric oxide production from activated macrophages.
178                                              Nitric oxide production from AMs of HHCs increased on Da
179  have indicated the importance of sufficient nitric oxide production from arginine during normal frac
180       In rat cerebellar slices, we activated nitric oxide production from each isoform of nitric oxid
181             Under proatherogenic conditions, nitric oxide production from endothelial cells is reduce
182  ectoenzyme on T cells, controls the rate of nitric oxide production from GSNO and thus markedly affe
183       However, to our knowledge, evidence of nitric oxide production from HU metabolism in humans has
184 se-mediated pathway as a potential source of nitric oxide production from hydroxyurea.
185                    These results demonstrate nitric oxide production from the ferric catalase oxidati
186 ium influx, tumor necrosis factor-alpha, and nitric oxide production in a concentration-dependent man
187 rasite Toxoplasma gondii is able to suppress nitric oxide production in activated macrophages.
188 herapy also significantly increased vascular nitric oxide production in apoE(-/-) mice.
189 -SP1 induced the ability of MSP-1 to inhibit nitric oxide production in bone marrow macrophages.
190                          Cytokines stimulate nitric oxide production in bone, and high concentrations
191 ble nitric oxide synthase and stimulation of nitric oxide production in chondrocytes by octacalcium p
192 mor growth assays reveal that Notch-mediated nitric oxide production in endothelial cell requires VEG
193     This study uncovers a novel mechanism of nitric oxide production in endothelial cells in tumors,
194  importance, shear stress does not stimulate nitric oxide production in endothelial cells on fibronec
195 RBC-derived ATP, which is known to stimulate nitric oxide production in endothelial cells, resulting
196                   In addition, it stimulates nitric oxide production in endothelial cells, which may
197 ylcooxygenases (COX-1 and COX-2), aromatase, nitric oxide production in endotoxin-stimulated macropha
198 ases in interleukin-8, GRO-alpha, MCP-1, and nitric oxide production in HeLa and AGS cells, despite s
199 ctive effect of copper depends on endogenous nitric oxide production in hippocampal neurons, demonstr
200 educed by 30% cytokine-induced apoptosis and nitric oxide production in INS-1E cells.
201 rk form the basis for real-time detection of nitric oxide production in living cells.
202 proinflammatory cytokines and suppression of nitric oxide production in macrophages.
203 pha-melanocyte-stimulating hormone regulates nitric oxide production in melanocytic cells by modulati
204                                              Nitric oxide production in murine J774A.1 cells, as well
205                              hVEGF-B induced nitric oxide production in NP macrophages (P < 0.05).
206 nefitted from (1) documentation of low nasal nitric oxide production in PCD and (2) discovery of bial
207 s work is to demonstrate that RBCs stimulate nitric oxide production in platelets by employing a cont
208  response against lipopolysaccharide-induced nitric oxide production in rat PBMCs were positively cor
209 tion of inducible nitric-oxide synthase, and nitric oxide production in RAW 264.7 cells.
210 anticoronavirus activity, and suppression of nitric oxide production in RAW264.7 cells (a measure of
211 hanisms that induce TIMSC and the effects on nitric oxide production in response to endotoxin.
212 ed by arterial endothelial cells, especially nitric oxide production in response to physiologic stimu
213                                     Enhanced nitric oxide production in sepsis is related to suggeste
214  nitric oxide synthase inhibitor to decrease nitric oxide production in septic shock.
215                     MnSOD siRNA also reduced nitric oxide production in supernatants of IPAH-ECs.
216 ain and prevented nerve injury-evoked excess nitric oxide production in the DRG, whereas administerin
217                                              Nitric oxide production in the grafts was increased by C
218 anisms of altered myocyte function caused by nitric oxide production in this setting are not establis
219 dothelial cell proliferation, migration, and nitric oxide production in vitro and increased expressio
220 creased inflammatory responses and increased nitric oxide production in vitro in response to Salmonel
221 dothelial nitric oxide synthase activity and nitric oxide production, increased aortic cyclooxygenase
222 oglia exposed to 15-30 microm zinc increased nitric oxide production, increased F4/80 expression, alt
223 and Ca(2+) influx, which activates low-level nitric oxide production, increases apical membrane Cl(-)
224 n; the finding that inhibiting superoxide or nitric oxide production inhibits both peroxynitrite prod
225  Inhibition of strain-related prostanoid and nitric oxide production inhibits strain-related (and bas
226 unctional analysis revealed that endothelial nitric oxide production is decreased by Notch inhibition
227 that MyD88- and Card9-mediated IFN-gamma and nitric oxide production is essential for protection agai
228 ible nitric oxide synthase, in which ROS and nitric oxide production is greatly decreased; (iii) a kn
229 ed association with actin filaments but peak nitric oxide production is transient due to actin S-nitr
230 lial dysfunction, characterized by decreased nitric oxide production, is one of the early features in
231  that arginase activity, which inhibits host nitric oxide production, is post-translationally stimula
232 ent increases in reactive oxygen species and nitric oxide production leading to increased caspase 3 a
233 pression profiles, oxygen consumption rates, nitric oxide production levels, shear stress responses,
234 s are associated with improper regulation of nitric oxide production, making NOS a therapeutic target
235  vessel wall shear stress and, consequently, nitric oxide production may contribute to heightened sys
236 ric oxide synthase--the gene responsible for nitric oxide production--may be affected by air pollutan
237                    The resulting increase in nitric-oxide production might be critical to the atherop
238 elerated calcium influx (n = 9) and enhanced nitric oxide production (n = 12) (vs four and eight cont
239 ue to defective oxidative phosphorylation or nitric oxide production), Na+ influx through voltage-gat
240 systemic hypertension or changes in cerebral nitric oxide production needs to be evaluated.
241 -X(L) in the regulation of cytosolic Ca(2+), nitric oxide production (NO), c-Jun NH(2)-terminal kinas
242 transport and ii) fluid shear stress induced nitric oxide production (NO).
243                                   Inhibiting nitric oxide production (Nomega-nitro-L-arginine, 50 mic
244 thelial nitric oxide synthase contributed to nitric oxide production, only inducible nitric oxide syn
245 he differences appear to be due to defective nitric oxide production or bioavailability and might exp
246 ot activate macrophage NF-kappa B signaling, nitric oxide production or inducible nitric-oxide syntha
247 tivation of NF-kappaB, but it did not affect nitric oxide production or iNOS gene expression.
248      Mitochondrial inhibition did not affect nitric oxide production or MAP kinase phosphorylation, w
249  M N(omega)-nitro-L-arginine (LNNA) to block nitric oxide production, or 10(-5) M glibenclamide to bl
250 t dsRNA + IFN-gamma-induced iNOS expression, nitric oxide production, or the inhibitory actions of th
251 dothelial sodium channel activation, reduced nitric oxide production, oxidative stress, and inflammat
252 ealthy children, HDL(CKD) strongly inhibited nitric oxide production, promoted superoxide production,
253                          Inhibition of local Nitric Oxide production reduced firing rates but did not
254 a demonstrate that differential flow-induced nitric oxide production regulates matrix-specific PAK si
255 ry network to modulate adaptive immunity via nitric oxide production, reminiscent of the monocytic su
256  deprivation can be attributed to diminished nitric oxide production resulting from the activity of t
257 e MEK/ERK pathway potentiates LPS-stimulated nitric oxide production, suggesting that LPS-stimulated
258 carrying mutant p53 and that a high level of nitric oxide production suppresses tumor growth and meta
259 ne stimulation in these cells also activated nitric oxide production that was blocked by sigma1-recep
260 ities (tubule formation, cell migration, and nitric oxide production) that were mediated by rcav-1 st
261 ency prevents NMDA receptors from triggering nitric oxide production, thereby attenuating the flow in
262 ages may determine the rate and magnitude of nitric oxide production, thereby regulating the cytotoxi
263 ut (KO) mice, indicating that the absence of nitric oxide production through iNOS is not compensated
264 ndothelial cells, PTX3 significantly blunted nitric oxide production through the matrix metalloprotei
265 lcium signals in primary cells that activate nitric oxide production to increase ciliary beating and
266 sRNA + IFN-gamma induces iNOS expression and nitric oxide production to similar levels by macrophages
267 ssembly of supramolecular complexes coupling nitric oxide production to upstream and downstream compo
268 hrough its regulation of eNOS expression and nitric oxide production to vascular hyperpermeability an
269 ant induction of reactive oxygen species and nitric oxide production trigger marrow vessel leakiness,
270 endently confirmed by an increase in myocyte nitric oxide production upon extracellular application o
271 ell-induced immunosuppression is mediated by nitric oxide production via inducible nitric oxide synth
272                                              Nitric oxide production was assessed by measuring the ra
273 ur previous studies showed that T/HS-induced nitric oxide production was associated with lung injury,
274                           Furthermore, renal nitric oxide production was decreased, and homogenates f
275 s cultured on more compliant substrates, and nitric oxide production was enhanced.
276                                      Splenic nitric oxide production was impaired in infected memTNF
277                                        Basal nitric oxide production was increased and endothelial ni
278                       Finally, inhibition of nitric oxide production was lethal, indicating that high
279                                              Nitric oxide production was measured by Griess reaction,
280                                              Nitric oxide production was measured by the Griess react
281                                TLR7-mediated nitric oxide production was measured using a fluorescent
282                                 Furthermore, nitric oxide production was prevented and, more importan
283                 To determine whether altered nitric oxide production was responsible, plasma nitrite
284 ducible nitric oxide synthase expression and nitric oxide production was severely impaired in the INS
285                                        Nasal nitric oxide production was very low in PCD (nl/minute;
286 ell lysis would be detrimental to epithelial nitric oxide production we hypothesized that perforin wa
287 els, cytokine levels, eicanosoid levels, and nitric oxide production were compared between strains.
288                  Cell proliferation rate and nitric oxide production were increased and apoptosis rat
289   Both Limulus amebocyte lysate activity and nitric oxide production were related to the degree of op
290            We further revealed that IL-6 and nitric oxide production were significantly higher by wil
291 nction and endothelial dependent relaxation (nitric oxide production) were determined using an organ
292 ate dehydrogenase membrane leakage assay and nitric oxide production, were used to determine if these
293 -induced activity of the HRE is dependent on nitric oxide production, which acts as a diffusible para
294 tis virus (EMCV) induces iNOS expression and nitric oxide production, which are unaffected by a domin
295     Moreover, endothelial stiffening reduces nitric oxide production, which promotes smooth muscle ce
296  and 23 mo) to characterize changes in renal nitric oxide production with age.
297 nti-TGF-beta treatment resulted in increased nitric oxide production within parasitized lesions.
298 function by increasing arginase activity and nitric oxide production, without affecting reactive oxyg
299       Reduction of HAP through inhibition of nitric oxide production worsened the recovery from FHVOO
300 eatment showed no effects on tube formation, nitric oxide production, wound healing or cell prolifera

 
Page Top